Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-16

Clinical Trial Update: Characterization of the Nrf2 Response in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

View source ↗

Summary

This clinical trial update describes a study assessing the Nrf2 response in patients with autosomal dominant polycystic kidney disease and is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Mayo Clinic | Conditions: Autosomal Dominant Polycystic Kidney Disease | Status: RECRUITING